Senmed, Inc. v. Richard-Allan Medical Industries, Inc.

Decision Date18 October 1989
Docket NumberRICHARD-ALLAN,No. 89-1091,89-1091
Citation888 F.2d 815,12 USPQ2d 1508
PartiesSENMED, INC. and Ethicon, Inc., Plaintiffs-Appellees, v.MEDICAL INDUSTRIES, INC., Defendant-Appellant.
CourtU.S. Court of Appeals — Federal Circuit

David E. Schmit, Frost & Jacobs, Cincinnati, Ohio, argued, for plaintiffs-appellees. With him on the brief was Roger A. Gilcrest.

Theodore W. Anderson, Neuman, Williams, Anderson & Olson, Chicago, Ill., argued, for defendant-appellant. With him on the brief was Todd P. Blakely.

Before MARKEY, Chief Judge, NEWMAN and ARCHER, Circuit Judges.

MARKEY, Chief Judge.

Appeal from a judgment entered by the United States District Court for the Western District of Michigan, No. K 84-444, on a jury verdict that Richard-Allan Medical Industries, Inc. (Richard-Allan) failed to establish invalidity of U.S. Patent No. 4,109,844 ('844) and that Senmed, Inc. and Ethicon, Inc. (collectively Senmed) proved Richard-Allan's willful infringement of that patent. We vacate in respect of validity and reverse in respect of infringement.

BACKGROUND

The claimed and accused devices are surgical staplers (skin staplers) that apply staples to close incisions or wounds. Unlike paper or stationery staplers, to which they are kin, skin staplers locate the staple-deforming anvil above the material to be stapled and deform the staple into a "box" shape rather than a tightly clenched configuration. Skin staples extend through the edges of skin tissue but remain open and able to flex when the tissue swells. To facilitate removal, the top of the staple is spaced slightly above the skin.

At trial, inventor Becht testified that, attributing unreliability of existing staplers to unnecessary complexity, he set forth to design a simpler device and focused on an area he considered the most complex, i.e., "the interface between where the staples are fed and where the staples were formed."

Becht's effort led to the '844 patent. Claim 1 reads:

A surgical stapling instrument for forming and implanting a staple in skin or fascia of a patient, said instrument comprising a handle portion incorporating a nose portion, said nose portion having an anvil plate at the bottom end thereof, said anvil plate terminating at its forward end in a coextensive anvil surface, said anvil plate being adapted to slidably mount a row of staples, means to constantly urge and advance said row of staples along said anvil plate to place a forwardmost staple on said anvil surface, a staple driver mounted in said nose portion and shiftable vertically between a normal upper position closely adjacent said forwardmost staple on said anvil surface and a lower position wherein it forms and implants said forwardmost staple about said anvil surface, and means to shift said staple driver between said upper and lower position thereof. 1

The Proceedings

On October 14, 1984, Senmed sued Richard-Allan, alleging, inter alia, infringement of the '844 patent. Following an exhaustive six-week trial, the jury returned a verdict in the form of answers to questions on anticipation, obviousness, infringement, and willfulness: 2

1. Do you unanimously find that the defendant Richard-Allan has proved by clear and convincing evidence that either of the asserted claims of the Becht 844 Patent is invalid because such claim was anticipated by a single prior art reference which disclosed each and every element of a claim arranged as in such claim?

[jury answer] Claim 1, no. Claim 2, no.

2. Do you unanimously find that the defendant Richard-Allan has proved by clear and convincing evidence that any of the asserted claims of the Becht 844 Patent is invalid because the differences between such claims and the pertinent prior art were such that the subject matter of the claim as a whole would have been obvious to a person having ordinary skill in the pertinent art at the time of the invention?

[jury answer] Claim 1, no. Claim 2, no.

3. Do you unanimously find that the defendant Richard-Allan has infringed upon any of the asserted claims of the Becht 844 Patent?

[jury answer] Claim 1, yes. Claim 2, yes.

4. If you find the Becht 844 Patent infringed, do you unanimously find by clear and convincing evidence that Richard-Allan willfully infringed upon the Becht 844 Patent?

[jury answer] Yes. 3

Richard-Allan moved for judgment NOV and for a new trial. Supplying a comprehensive opinion, the trial judge denied the motions and entered judgment in accord with the jury answers that constituted the verdict.

In his well written opinion, the trial judge discussed the evidence and Richard-Allan's arguments in relation to literal infringement, infringement under the doctrine of equivalents, anticipation, obviousness, willful infringement, jury instructions, and an evidentiary ruling. The court noted that the credibility of Richard-Allan's sole witness on anticipatory art could "reasonably be questioned." Thrice noting that Richard-Allan "provided no testimony from an expert with ordinary skill in the art of skin stapling," the court adopted inventor Becht's claim-interpreting testimony in upholding jury answer 3 on infringement.

Richard-Allan here contends that certain of the jury's answers are unsupportable and that the trial judge therefore erred in refusing to enter judgment NOV. Admirably, it does not burden this court with challenges on the denial of its motion for a new trial, the correctness of any jury instruction, jury answer 1 (anticipation), or jury answer 4 (willfulness), but limits its appeal to jury answer 2 (obviousness) and jury answer 3 (infringement).

ISSUE

Whether the judgment entered on the jury verdict of infringement can be sustained in law.

OPINION
Introduction

To succeed here, Richard-Allan must show that the jury's finding of infringement is not supported by substantial evidence or that it was made in relation to a claim interpretation that cannot in law be sustained. See ZMI Corp. v. Cardiac Resuscitator Corp., 844 F.2d 1576, 1581-82, 6 USPQ2d 1557, 1561-61 (Fed.Cir.1988). After careful review of the record, we are convinced that Richard-Allan satisfied the latter criterion. We must, therefore, reverse the judgment entered on the jury verdict of infringement. 4

Richard-Allan says the "jury and the district court misconstrued the scope of claim 1" and that the claim, "properly construed," cannot be read on its device. It argues that the claim limitation "means to constantly urge and advance said row of staples along said anvil plate to place a forwardmost staple on said anvil surface" cannot be read on its device because its advancing means places a forwardmost staple above its anvil. Stated differently, Richard-Allan says "on" the anvil surface must be interpreted as meaning "in physical contact with" the anvil surface. 5

There was, at the pretrial, trial, and post-trial stages, an intense focus on claim interpretation. That an appellant's arguments had been ineptly presented to a trial court does not in itself preclude a reversal by this court if the record unequivocally establishes that the appealed judgment resulted from clear and reversible legal error. We cannot and will not, as Richard-Allan would have us do, substitute our view of facts, or re-try the case, or ignore all the events that occurred before the appeal. Construction of claim scope (claim interpretation), however, is a question of law for decision by the trial judge on motion for JNOV and by this court on appeal. Johnston v. IVAC Corp., 885 F.2d 1574, 1579 (Fed.Cir.1989); Standard Oil Co. v. American Cyanamid Co., 774 F.2d 448, 452, 227 USPQ 293, 295-96 (Fed.Cir.1985); Loctite Corp. v. Ultraseal Ltd., 781 F.2d 861, 866, 228 USPQ 90, 93 (Fed.Cir.1985); Fromson v. Advance Offset Plate, Inc., 720 F.2d 1565, 1569, 219 USPQ 1137, 1140 (Fed.Cir.1983). That a jury has answered a legal question may not in itself require reversal. Of a certainty, however, that circumstance cannot serve to relieve the trial judge or this court of the judicial duty to insure that the law is correctly applied. That duty hangs heavy on an appellate court when, as here, it necessitates reversal after a six week trial and a denial of a motion for JNOV. 6

Claim Interpretation

In answering an infringement inquiry one must first interpret the claim. Mannesmann Demag Corp. v. Engineered Metal Prods. Co., 793 F.2d 1279, 1282, 230 USPQ 45, 46 (Fed.Cir.1986). Once an interpretation has been made, that same interpretation must be employed in determining literal infringement and infringement under the doctrine of equivalents. See Loctite, 781 F.2d at 870-71, 228 USPQ at 96. 7 The claim here is interpreted in light of the probative facts in the record, i.e., all of the claim's language, the specification, and the prosecution history. See Fromson, 720 F.2d at 1569-71, 219 USPQ at 1140-42.

Here the jury returned a naked verdict stating the ultimate fact of infringement. That circumstance requires the district court, and this court on appeal, to presume not only the jury's claim interpretation but also the findings necessary to support that interpretation. See Newell Cos. v. Kenney Mfg. Co., 864 F.2d 757, 767-68, 9 USPQ2d 1417, 1426 (Fed.Cir.1988). Whether the jury premised its infringement finding on a literal reading of the claim or on the doctrine of equivalents, the claim interpretation necessary to support a finding of infringement cannot in this case be supported by the record. The claim language, specification, and prosecution history belie the claim interpretation asserted by Becht, necessarily arrived at by the jury, and adopted by the district court.

In interpreting the claim language "on said anvil surface," the district court relied on Becht's testimony that the phrase means the staple is placed "between the upper surface of the anvil, the coextensive anvil surface, and the lower limit of whatever abutting means is above it"...

To continue reading

Request your trial
82 cases
  • Atlantic Thermoplastics Co., Inc. v. Faytex Corp.
    • United States
    • U.S. Court of Appeals — Federal Circuit
    • 13 Julio 1992
    ...litigation. In any event, claims mean the same for infringement and validity. See, e.g., Senmed, Inc. v. Richard-Allan Medical Indus., 888 F.2d 815, 818 n. 7, 12 USPQ2d 1508, 1511 n. 7 (Fed.Cir.1989); Kimberly-Clark Corp. v. Johnson & Johnson, 745 F.2d 1437, 223 USPQ 603 (Fed.Cir.1984). Mor......
  • Ziggity Systems, Inc. v. Val Watering Systems
    • United States
    • U.S. District Court — Eastern District of Pennsylvania
    • 14 Noviembre 1990
    ...the scope of Claim 19 of the '345 patent is no less broad under the doctrine of equivalents. See Senmed, Inc. v. Richard-Allan Medical Indus., Inc., 888 F.2d 815, 821 (Fed.Cir.1989). The only arguments submitted in support of Claim 19 (Claim 32 in the following remarks) were as Claims 14, 1......
  • Biagro Western Sales, Inc. v. Helena Chemical Co., CIV. F. No. 01-5014 OWW DLB.
    • United States
    • U.S. District Court — Eastern District of California
    • 7 Mayo 2001
    ...may not be heard to contend that the patent's scope is much broader than stated. See, e.g., Senmed, Inc. v. Richard-Allen Medical Indus., Inc., 888 F.2d 815, 819 n. 9 (Fed. Cir.1989). "A patent may not, like a `nose of wax,' be twisted one way to avoid anticipation and another to find infri......
  • Merck & Co., Inc. v. Mylan Pharmaceuticals, CIVIL ACTION NO. 97-CV-4241 (E.D. Pa. 8/__/1998)
    • United States
    • U.S. District Court — Eastern District of Pennsylvania
    • 1 Agosto 1998
    ...1570, 1578 (Fed.Cir.), cert. denied, 516 U.S. 987, 116 S.Ct. 515, 133 L.Ed.2d 424 (1995), quoting Senmed, Inc. v. Richard-Allan Med. Indus., Inc., 888 F.2d 815, 819 n. 8 (Fed.Cir. 1989)); see also Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1583 (Fed.Cir. 1996)("In those cases wher......
  • Request a trial to view additional results
3 books & journal articles
  • Markman Twenty Years Later: Twenty Years of Unintended Consequences
    • United States
    • University of Washington School of Law Journal of Law, Technology & Arts No. 10-4, June 2015
    • Invalid date
    ...Before Markman, "semantic antics" were roundly condemned by the Federal Circuit. E.g., Senmed, Inc. v. Richard-Allan Med. Indus., Inc., 888 F.2d 815, 819 (Fed. Cir. 1989) (citing Burlington Indus., Inc. v. Dayco Corp., 849 F.2d 1418, 1421-22 (Fed. Cir. 1988)). 70. Id. at 979 (quoting Willia......
  • Markman v. Westview Instruments, Inc.: the Supreme Court Narrows the Jury's Role in Patent Litigation - Elizabeth J. Norman
    • United States
    • Mercer University School of Law Mercer Law Reviews No. 48-2, January 1997
    • Invalid date
    ...1107 (Fed. Cir. 1985); Specialty Composites v. Cabot Corp., 845 F.2d 981 (Fed. Cir. 1988); Senmed, Inc. v. Richard-Allan Medical Indus., 888 F.2d 815 (Fed. Cir. 1989); Unique Concepts, Inc. v. Brown, 939 F.2d 1558 (Fed. Cir. 1991); Intellicall, Inc. v. Phonometrics, Inc., 952 F.2d 1384 (Fed......
  • Chapter §15.02 Judge Versus Jury as Interpreter
    • United States
    • Full Court Press Mueller on Patent Law Volume II: Patent Enforcement Title CHAPTER 15 Patent Claim Interpretation
    • Invalid date
    ...that case "require[d] an interpretation by the court of the patent claims at issue"); Senmed, Inc. v. Richard-Allan Med. Indus., Inc., 888 F.2d 815, 818 (Fed. Cir. 1989) (reversing judgment for patentee following jury verdict that patent directed to surgical staplers was infringed where app......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT